{"id":61084,"date":"2023-12-04T11:08:45","date_gmt":"2023-12-04T02:08:45","guid":{"rendered":"https:\/\/monolith.law\/tr\/?p=61084"},"modified":"2024-03-20T00:22:03","modified_gmt":"2024-03-19T15:22:03","slug":"supplement-definition-advertising-rules","status":"publish","type":"post","link":"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules","title":{"rendered":"\u0130la\u00e7 Cihaz Yasas\u0131'na (Japanese Pharmaceutical and Medical Device Act) Ba\u011fl\u0131 G\u0131da Takviyelerinin Tan\u0131m\u0131 ve Reklam \u0130fadelerine Dikkat Edilmesi Gerekenler"},"content":{"rendered":"\n<p>G\u00fcnl\u00fck ya\u015famda eksik kalan besinleri tamamlamak i\u00e7in takviye kullanmay\u0131 tercih eden bir\u00e7ok ki\u015fi bulunmaktad\u0131r. Takviyeler, eczanelerde ve benzeri yerlerde bulunabildi\u011fi gibi, teleshop programlar\u0131 ve dergi reklamlar\u0131nda da sat\u0131lmaktad\u0131r ve g\u00fcnl\u00fck ya\u015famda kar\u015f\u0131la\u015fma olas\u0131l\u0131\u011f\u0131m\u0131z artmaktad\u0131r.<\/p>\n\n\n\n<p>Bu t\u00fcr takviyeleri satarken, reklamlar\u0131n hukuki d\u00fczenlemeler a\u00e7\u0131s\u0131ndan, takviyenin bir ila\u00e7 m\u0131 yoksa bir g\u0131da maddesi mi oldu\u011fu \u00e7ok \u00f6nemlidir. Bilmeden reklam yaparsan\u0131z, fark\u0131nda olmadan yasa d\u0131\u015f\u0131 bir eylem ger\u00e7ekle\u015ftirebilir ve cezalar uygulanabilir, bu da i\u015fletmenize b\u00fcy\u00fck zararlar verebilir.<\/p>\n\n\n\n<p>Bu makalede, takviyelerin do\u011fas\u0131 ve reklamlarda dikkat edilmesi gereken ifadeler hakk\u0131nda bilgi verilecektir.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_53 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Ilac_ve_Tibbi_Cihaz_Yasasi_Nedir\" title=\"\u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 Nedir?\">\u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 Nedir?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Takviyelerin_Tanimi\" title=\"Takviyelerin Tan\u0131m\u0131\">Takviyelerin Tan\u0131m\u0131<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Takviyeler_ve_Saglikli_Gidalarin_Farki\" title=\"Takviyeler ve Sa\u011fl\u0131kl\u0131 G\u0131dalar\u0131n Fark\u0131\">Takviyeler ve Sa\u011fl\u0131kl\u0131 G\u0131dalar\u0131n Fark\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Takviyeler_ve_Ilaclarin_Farki\" title=\"Takviyeler ve \u0130la\u00e7lar\u0131n Fark\u0131\">Takviyeler ve \u0130la\u00e7lar\u0131n Fark\u0131<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Ilac_Makinesi_Yasasi_ile_Takviyelerin_Neden_Denetlendigi\" title=\"\u0130la\u00e7 Makinesi Yasas\u0131 ile Takviyelerin Neden Denetlendi\u011fi\">\u0130la\u00e7 Makinesi Yasas\u0131 ile Takviyelerin Neden Denetlendi\u011fi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Takviye_Ilaclarinin_Japon_Ilac_Yasasi_Japanese_Pharmaceuticals_and_Medical_Devices_Act_Kapsaminda_Reklam_Ifadelerine_Dikkat\" title=\"Takviye \u0130la\u00e7lar\u0131n\u0131n Japon \u0130la\u00e7 Yasas\u0131 (Japanese Pharmaceuticals and Medical Devices Act) Kapsam\u0131nda Reklam \u0130fadelerine Dikkat\">Takviye \u0130la\u00e7lar\u0131n\u0131n Japon \u0130la\u00e7 Yasas\u0131 (Japanese Pharmaceuticals and Medical Devices Act) Kapsam\u0131nda Reklam \u0130fadelerine Dikkat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Ozet_Gida_Takviyelerinin_Reklamlarina_Avukatin_Hukuki_Kontrolu_Gerekir\" title=\"\u00d6zet: G\u0131da Takviyelerinin Reklamlar\u0131na Avukat\u0131n Hukuki Kontrol\u00fc Gerekir\">\u00d6zet: G\u0131da Takviyelerinin Reklamlar\u0131na Avukat\u0131n Hukuki Kontrol\u00fc Gerekir<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/supplement-definition-advertising-rules\/#Buromuz_Tarafindan_Alinan_Onlemler\" title=\"B\u00fcromuz Taraf\u0131ndan Al\u0131nan \u00d6nlemler\">B\u00fcromuz Taraf\u0131ndan Al\u0131nan \u00d6nlemler<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ilac_ve_Tibbi_Cihaz_Yasasi_Nedir\"><\/span>\u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 Nedir?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh3.googleusercontent.com\/A0pjQ9xaNYzXtqtBrqGeQMFw2rOrZlPAuKCxAU37uLrfGCeq5E3xkhR0kYlIw7QJK4ijrRlNFFQdQZ2xzEf1-ecSY2OnD96KVreXMk6MyoqDyDGpQygX2UOlWhQudpzHdalDaTz6ZGNMooPKgxBVnoNx5ieZxyJ30b32-FJ2AcJUovzyHeay5-xYOPMWFw\" alt=\"\u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 Nedir?\" \/><\/figure>\n\n\n\n<p>\u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 (Japon \u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131), ila\u00e7lar, t\u0131bbi cihazlar, ila\u00e7 d\u0131\u015f\u0131 \u00fcr\u00fcnler ve kozmetikler gibi \u00fcr\u00fcnleri hedef alan bir yasad\u0131r. Bu yasa, \u00fcr\u00fcnlerin kalitesini, etkinli\u011fini ve g\u00fcvenli\u011fini sa\u011flamak, sa\u011fl\u0131k ve hijyen \u00fczerindeki zararlar\u0131n olu\u015fumunu ve yay\u0131lmas\u0131n\u0131 \u00f6nlemek i\u00e7in gerekli \u00f6nlemleri almay\u0131 ama\u00e7lar (\u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 Madde 1).<\/p>\n\n\n\n<p>\u0130la\u00e7lar ve benzeri \u00fcr\u00fcnler kullan\u0131c\u0131lar\u0131n sa\u011fl\u0131\u011f\u0131 \u00fczerinde \u00f6nemli etkileri olabilecek \u00fcr\u00fcnler oldu\u011fundan, \u00fcretim, sat\u0131\u015f, reklam gibi \u00e7e\u015fitli faaliyetler \u0130la\u00e7 ve T\u0131bbi Cihaz Yasas\u0131 kapsam\u0131nda d\u00fczenlenmi\u015ftir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Takviyelerin_Tanimi\"><\/span>Takviyelerin Tan\u0131m\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Takviyelerin asl\u0131nda idari bir tan\u0131m\u0131 yoktur ve genellikle &#8220;belirli bile\u015fenlerin yo\u011funla\u015ft\u0131r\u0131ld\u0131\u011f\u0131 tablet veya kaps\u00fcl formundaki \u00fcr\u00fcnler&#8221; olarak d\u00fc\u015f\u00fcn\u00fcl\u00fcr.<\/p>\n\n\n\n<p>Ancak, insanlar\u0131n a\u011f\u0131z yoluyla t\u00fcketti\u011fi g\u0131dalar, &#8220;g\u0131da&#8221; ve &#8220;ila\u00e7lar vb.&#8221; olarak ayr\u0131l\u0131r (Japon G\u0131da G\u00fcvenli\u011fi Temel Yasas\u0131 Madde 2 F\u0131kra 1, Japon G\u0131da Hijyen Yasas\u0131 Madde 4 F\u0131kra 1&#8217;e bak\u0131n\u0131z) ve &#8220;ila\u00e7lar vb.&#8221; kategorisine girip girmedi\u011fi, Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131 Madde 2 F\u0131kra 1&#8217;e g\u00f6re belirlenir. Takviyeler, &#8220;ila\u00e7lar vb.&#8221; tan\u0131m\u0131na uymad\u0131\u011f\u0131 i\u00e7in, sonu\u00e7ta g\u0131da olarak kabul edilirler.<\/p>\n\n\n\n<p>Dolay\u0131s\u0131yla, takviyelerin sat\u0131\u015f\u0131 ve reklam\u0131 hakk\u0131nda, genellikle Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131&#8217;n\u0131n d\u00fczenlemeleri uygulanmaz, bunun yerine Japon \u00d6d\u00fcl G\u00f6sterim Yasas\u0131 veya Japon Sa\u011fl\u0131k Geli\u015ftirme Yasas\u0131 gibi yasalar\u0131n d\u00fczenlemelerine tabi olurlar.<\/p>\n\n\n\n<p>Yine de, takviyelerin \u015fekli tablet veya kaps\u00fcl \u015feklinde olabilir ve ila\u00e7 gibi bir g\u00f6r\u00fcn\u00fc\u015fe sahip olabilirler. Bu t\u00fcr durumlarda, a\u015fa\u011f\u0131da belirtildi\u011fi gibi, ila\u00e7 olarak kabul edilir ve Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131&#8217;n\u0131n d\u00fczenlemelerine tabi olabilirler.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Takviyeler_ve_Saglikli_Gidalarin_Farki\"><\/span>Takviyeler ve Sa\u011fl\u0131kl\u0131 G\u0131dalar\u0131n Fark\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Takviyeler gibi, sa\u011fl\u0131kl\u0131 g\u0131dalar\u0131n da idari bir tan\u0131m\u0131 yoktur ve genellikle &#8220;sa\u011fl\u0131\u011f\u0131n korunmas\u0131n\u0131 ve geli\u015ftirilmesini destekleyen t\u00fcm g\u0131dalar&#8221; olarak d\u00fc\u015f\u00fcn\u00fcl\u00fcr. Ayr\u0131ca, s\u0131n\u0131fland\u0131rma a\u00e7\u0131s\u0131ndan &#8220;g\u0131da&#8221; kategorisine girerler, bu da takviyelerle ayn\u0131d\u0131r.<\/p>\n\n\n\n<p>Yine de, sa\u011fl\u0131kl\u0131 g\u0131dalar aras\u0131nda, bile\u015fenlerin i\u015flevlerinin reklamlar\u0131nda g\u00f6sterilebildi\u011fi &#8220;Sa\u011fl\u0131k Fonksiyonel G\u0131da Sistemi&#8221;nin kullan\u0131ld\u0131\u011f\u0131 \u00fcr\u00fcnler bulunmaktad\u0131r. Takviyeler, &#8220;Sa\u011fl\u0131k Fonksiyonel G\u0131da Sistemi&#8221;nin kullan\u0131lmad\u0131\u011f\u0131, yani &#8220;sa\u011fl\u0131kl\u0131 g\u0131dalar&#8221; olarak adland\u0131r\u0131lan \u00fcr\u00fcnler aras\u0131nda s\u0131n\u0131fland\u0131r\u0131l\u0131r.<\/p>\n\n\n\n<p>Sa\u011fl\u0131kl\u0131 g\u0131dalar\u0131n \u00f6zellikleri ve sa\u011fl\u0131kl\u0131 g\u0131dalar\u0131n reklam g\u00f6sterimleri hakk\u0131nda, ba\u015fka bir makalede a\u00e7\u0131klama yap\u0131lm\u0131\u015ft\u0131r, l\u00fctfen ba\u015fvurunuz.<\/p>\n\n\n\n<p>\u0130lgili Makale: <a href=\"https:\/\/monolith.law\/corporate\/pharmaceuticals-advertising-regulations\" target=\"_blank\" rel=\"noreferrer noopener\">Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131&#8217;n\u0131n Reklam D\u00fczenlemeleri Nedir? Yasal \u0130fadelerle Reklam Olu\u015fturman\u0131n P\u00fcf Noktalar\u0131n\u0131 A\u00e7\u0131kl\u0131yoruz[ja]<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Takviyeler_ve_Ilaclarin_Farki\"><\/span>Takviyeler ve \u0130la\u00e7lar\u0131n Fark\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Daha \u00f6nce belirtildi\u011fi gibi, bir \u00fcr\u00fcn\u00fcn &#8220;ila\u00e7&#8221; olarak kabul edilip edilmedi\u011fi, Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131 Madde 2 F\u0131kra 1&#8217;e g\u00f6re belirlendi\u011fi i\u00e7in, takviyeler ve ila\u00e7lar aras\u0131nda net bir ayr\u0131m yap\u0131l\u0131r.<\/p>\n\n\n\n<p>Ancak, \u00fcr\u00fcn\u00fcn \u015fekli veya reklam\u0131n g\u00f6sterimi nedeniyle, bir g\u0131da bile ila\u00e7 olarak kabul edilebilir ve takviyeler de ila\u00e7 olarak kabul edilebilir.<\/p>\n\n\n\n<p>Bir ila\u00e7\u0131n \u00fcretimi veya sat\u0131\u015f\u0131 i\u00e7in Japon Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakan\u0131&#8217;n\u0131n onay\u0131 veya izni gerekti\u011fi halde, ila\u00e7 olarak kabul edilen g\u0131dalar bu onaylar\u0131 almadan \u00fcretilir veya sat\u0131l\u0131r, bu nedenle &#8220;onays\u0131z ve izinsiz ila\u00e7lar&#8221; olarak adland\u0131r\u0131l\u0131rlar.<\/p>\n\n\n\n<p>Uygun onay veya izin al\u0131nmadan ila\u00e7 \u00fcretme veya satma durumunda, 3 y\u0131la kadar hapis cezas\u0131 veya 3 milyon yen (yakla\u015f\u0131k 27.000 dolar) veya her ikisi de uygulanabilir. Bu nedenle, takviyelerin \u00fcretimi ve sat\u0131\u015f\u0131n\u0131 yaparken, ila\u00e7 olarak kabul edilmeyecek \u015fekilde dikkatli olunmal\u0131d\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ilac_Makinesi_Yasasi_ile_Takviyelerin_Neden_Denetlendigi\"><\/span>\u0130la\u00e7 Makinesi Yasas\u0131 ile Takviyelerin Neden Denetlendi\u011fi<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh6.googleusercontent.com\/C8f5n2CmvipiuvU7P39FIbHC1W_gmIDZYY0uzXejkomQ-8DOldhb3ncFSE_YVfLmhPFNYBfDB6r09cLTrAASSbpV8I7TE2AJms5RRFQUXOvd_uhAkcKNm44AfZTRFJR-lbvHKWE1yYtutnirPDEZZdNhXpYyPWIdnoWMog0LawYCwB7ifdkyTTQ4yGNHHA\" alt=\"\u0130la\u00e7 Makinesi Yasas\u0131 ile Takviyelerin Neden Denetlendi\u011fi\" \/><\/figure>\n\n\n\n<p>Takviyelerin ila\u00e7larla ayn\u0131 bile\u015fenleri i\u00e7ermesi veya reklamlarda ila\u00e7larla kar\u0131\u015ft\u0131r\u0131lacak etki ve etkinlikler belirtmesi durumunda, ila\u00e7lar\u0131n onay ve izin sistemini atlayarak onays\u0131z ve izinsiz ila\u00e7larla e\u015fde\u011fer \u00fcr\u00fcnlerin sat\u0131\u015f\u0131 m\u00fcmk\u00fcn hale gelir. Bu durum, devletin g\u00fcvencesinin sa\u011flanmad\u0131\u011f\u0131 \u00fcr\u00fcnlerin piyasaya s\u00fcr\u00fclmesine yol a\u00e7ar.<\/p>\n\n\n\n<p>Bu durum ger\u00e7ekle\u015firse, insan v\u00fccuduna \u00e7e\u015fitli zararlar vererek sa\u011fl\u0131k sorunlar\u0131na neden olabilece\u011fi i\u00e7in, ila\u00e7larla ayn\u0131 bile\u015fenleri i\u00e7eren \u00fcr\u00fcnler veya ila\u00e7larla kar\u0131\u015ft\u0131r\u0131lacak etki ve etkinlikler belirten reklamlar, &#8220;ila\u00e7&#8221; olarak kabul edilir ve onay veya izin olmadan \u00fcretim ve sat\u0131\u015f gibi faaliyetlerde bulunmak, yukar\u0131da belirtildi\u011fi gibi a\u011f\u0131r cezalarla kar\u015f\u0131la\u015f\u0131r.<\/p>\n\n\n\n<p>Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakanl\u0131\u011f\u0131&#8217;n\u0131n web sitesinde, onays\u0131z ve izinsiz ila\u00e7 bilgilerinin yay\u0131nland\u0131\u011f\u0131 b\u00f6l\u00fcmler hakk\u0131nda a\u015fa\u011f\u0131daki uyar\u0131lar\u0131 belirtmi\u015ftir:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>Onays\u0131z ve izinsiz ila\u00e7lar, Japon ila\u00e7lar\u0131, t\u0131bbi cihazlar vb. kalite, etkinlik ve g\u00fcvenli\u011fin sa\u011flanmas\u0131 hakk\u0131ndaki yasaya dayal\u0131 kalite, etkinlik ve g\u00fcvenlik do\u011frulamas\u0131 yap\u0131lmam\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>Tespit edilen ila\u00e7 bile\u015fenlerinin i\u00e7eri\u011fi her zaman e\u015fit olmayabilir ve bir seferde al\u0131nd\u0131\u011f\u0131nda sa\u011fl\u0131k sorunlar\u0131na neden olabilecek miktarlar i\u00e7erebilir.<\/p>\n\n\n\n<p>Ayr\u0131ca, hijyenik olmayan yerlerde veya y\u00f6ntemlerle \u00fcretilmi\u015f olabilece\u011fi i\u00e7in, zararl\u0131 safs\u0131zl\u0131klar\u0131n i\u00e7erilme olas\u0131l\u0131\u011f\u0131 reddedilemez. Bildirilen sa\u011fl\u0131k sorunlar\u0131, tespit edilen ila\u00e7 bile\u015fenlerinden kaynaklananlarla s\u0131n\u0131rl\u0131 olmay\u0131p, bu t\u00fcr safs\u0131zl\u0131klar\u0131n da etkili olabilece\u011fi olas\u0131l\u0131\u011f\u0131 vard\u0131r.<\/p>\n<cite>(Kaynak: <a href=\"https:\/\/www.mhlw.go.jp\/stf\/kinkyu\/diet\/musyounin.html\" target=\"_blank\" rel=\"noreferrer noopener\">Onays\u0131z ve \u0130zinsiz \u0130la\u00e7 Bilgileri | Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakanl\u0131\u011f\u0131[ja]<\/a>)<\/cite><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Takviye_Ilaclarinin_Japon_Ilac_Yasasi_Japanese_Pharmaceuticals_and_Medical_Devices_Act_Kapsaminda_Reklam_Ifadelerine_Dikkat\"><\/span>Takviye \u0130la\u00e7lar\u0131n\u0131n Japon \u0130la\u00e7 Yasas\u0131 (Japanese Pharmaceuticals and Medical Devices Act) Kapsam\u0131nda Reklam \u0130fadelerine Dikkat<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh4.googleusercontent.com\/RN-akrEL8BJLGHST5mq9QRY_SAJ1827w-usMvQPpu7W9ui_YZz6m9rAmOJsoqmamn5QifGNm98robr0RgIPOPmpysqBHSKK8GPREJIXKWQv6DbhZJbUqKJPlOkov0WnL_DXn-0RCjvED06Ydhvf2kAKVr_rmX9M3j2TPzkVXWJNgprbh_aKwk_XgUiFhcw\" alt=\"Takviye \u0130la\u00e7lar\u0131n\u0131n Japon \u0130la\u00e7 Yasas\u0131 Kapsam\u0131nda Reklam \u0130fadelerine Dikkat\" \/><\/figure>\n\n\n\n<p>Takviye ila\u00e7lar\u0131n\u0131n ve benzeri \u00fcr\u00fcnlerin t\u0131bbi \u00fcr\u00fcn olarak kabul edilip edilmedi\u011fi konusunda yorum yaparken dikkate al\u0131nmas\u0131 gereken noktalar \u015funlard\u0131r:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<ul>\n<li>&nbsp;Etkinlik, \u015fekil ve kullan\u0131m dozu ne olursa olsun, 1. kriter (\u203bBir maddenin \u00f6z\u00fc (ham madde), yaln\u0131zca t\u0131bbi \u00fcr\u00fcn olarak kullan\u0131lan bir maddenin \u00f6z\u00fc (ham madde) olarak kabul edilirse) uyar\u0131nca, yaln\u0131zca t\u0131bbi \u00fcr\u00fcn olarak kullan\u0131lan bir maddenin \u00f6z\u00fc (ham madde) (yaln\u0131zca t\u0131bbi \u00fcr\u00fcn olarak kullan\u0131lan maddelerin listesinde yer alanlar) i\u00e7eriyorsa, genellikle t\u0131bbi \u00fcr\u00fcn kapsam\u0131nda kabul edilir.<\/li>\n\n\n\n<li>&nbsp;1. kritere uymayan bir maddenin \u00f6z\u00fc (ham madde) i\u00e7eriyorsa ve a\u015fa\u011f\u0131daki \u2460&#8217;den \u2462&#8217;e kadar olan durumlardan birine uyuyorsa, genellikle t\u0131bbi \u00fcr\u00fcn olarak kabul edilir.<\/li>\n<\/ul>\n\n\n\n<p>\u2460 T\u0131bbi etkinlik iddia edenler<\/p>\n\n\n\n<p>\u2461 Ampul \u015feklinde olanlar ve benzeri yaln\u0131zca t\u0131bbi \u00fcr\u00fcn \u015feklinde olanlar<\/p>\n\n\n\n<p>\u2462 Kullan\u0131m dozu t\u0131bbi \u00fcr\u00fcnler gibi olanlar<\/p>\n<cite>(Kaynak: &#8220;<a href=\"https:\/\/www.mhlw.go.jp\/content\/000658257.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Onay Al\u0131nmam\u0131\u015f ve \u0130zin Verilmemi\u015f \u0130la\u00e7lar\u0131n Denetimi[ja]<\/a>&#8220;)<\/cite><\/blockquote>\n\n\n\n<p>Yaln\u0131zca t\u0131bbi \u00fcr\u00fcnlerde kullan\u0131lan maddeleri i\u00e7erip i\u00e7ermedi\u011fi de\u011fil, \u00fcr\u00fcn\u00fcn \u015fekli ve kullan\u0131m dozu gibi fakt\u00f6rler de t\u0131bbi \u00fcr\u00fcn olarak kabul edilme riskini ta\u015f\u0131d\u0131\u011f\u0131ndan, dikkatli olunmal\u0131d\u0131r.<\/p>\n\n\n\n<p>Ayr\u0131ca, onay al\u0131nmam\u0131\u015f ve izin verilmemi\u015f ila\u00e7lar t\u0131bbi \u00fcr\u00fcn olarak kabul edildi\u011finden, Japon \u0130la\u00e7 Yasas\u0131&#8217;n\u0131n reklam d\u00fczenlemelerine tabi olurlar. Japon \u0130la\u00e7 Yasas\u0131&#8217;n\u0131n 68. maddesi, onay al\u0131nmadan ila\u00e7lar\u0131n ad\u0131n\u0131n, \u00fcretim y\u00f6nteminin, etkinli\u011finin ve performans\u0131n\u0131n reklam\u0131n\u0131 yasaklar. Bu maddeye ayk\u0131r\u0131 hareket edenler, 2 y\u0131la kadar hapis veya 2 milyon yen (yakla\u015f\u0131k 18.000 dolar) para cezas\u0131 veya her ikisiyle de cezaland\u0131r\u0131labilirler. Ayr\u0131ca, reklam\u0131n durdurulmas\u0131 veya tekrarlanmamas\u0131 i\u00e7in emirler alabilirler.<\/p>\n\n\n\n<p>Emirler hakk\u0131nda ayr\u0131nt\u0131l\u0131 bilgi i\u00e7in, ba\u015fka bir makalemizi inceleyebilirsiniz.<\/p>\n\n\n\n<p>\u0130lgili Makale: <a href=\"https:\/\/monolith.law\/corporate\/pharmaceuticals-law-surcharge\" target=\"_blank\" rel=\"noreferrer noopener\">Japon \u0130la\u00e7 Yasas\u0131&#8217;n\u0131n Para Cezas\u0131 Sistemi Nedir? Hedef Al\u0131nan Davran\u0131\u015flar ve \u0130ndirim Uygulanan Durumlar[ja]<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ozet_Gida_Takviyelerinin_Reklamlarina_Avukatin_Hukuki_Kontrolu_Gerekir\"><\/span>\u00d6zet: G\u0131da Takviyelerinin Reklamlar\u0131na Avukat\u0131n Hukuki Kontrol\u00fc Gerekir<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Bu \u015fekilde, bir g\u0131da takviyesi olarak \u00fcretim ve sat\u0131\u015f yapmay\u0131 planlasan\u0131z bile, kullan\u0131lan bile\u015fenler, \u00fcr\u00fcn\u00fcn \u015fekli, reklam\u0131n g\u00f6sterimi gibi nedenlerle &#8220;ila\u00e7&#8221; olarak kabul edilebilir. E\u011fer bu durum ger\u00e7ekle\u015firse, \u00fcretimin durdurulmas\u0131 veya reklam d\u00fczenlemelerine ayk\u0131r\u0131l\u0131k nedeniyle para cezas\u0131 gibi, i\u015fletmenize b\u00fcy\u00fck zararlar verebilir.<\/p>\n\n\n\n<p>G\u0131da takviyesi \u00fcretme, satma veya reklam olu\u015fturma konusunda en ufak bir endi\u015feniz varsa, &#8216;Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131&#8217;na (Pharmaceuticals and Medical Devices Act) a\u015fina bir avukata dan\u0131\u015fmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/p>\n\n\n\n<p>G\u0131da takviyeleri gibi \u00fcr\u00fcnlerin reklamlar\u0131n\u0131n hukuki kontrol\u00fc ve ifade de\u011fi\u015fikli\u011fi \u00f6nerileri, olduk\u00e7a uzmanl\u0131k gerektiren bir aland\u0131r. Monolith Hukuk B\u00fcrosu, &#8216;Japon \u0130la\u00e7lar ve T\u0131bbi Cihazlar Yasas\u0131&#8217; hukuk ekibini olu\u015fturmu\u015f ve g\u0131da takviyelerinden ila\u00e7lara kadar \u00e7e\u015fitli \u00fcr\u00fcnlerin makale kontrolleri gibi konulara yan\u0131t vermektedir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Buromuz_Tarafindan_Alinan_Onlemler\"><\/span>B\u00fcromuz Taraf\u0131ndan Al\u0131nan \u00d6nlemler<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Monolith Hukuk B\u00fcrosu, \u00f6zellikle IT ve hukuk alanlar\u0131nda geni\u015f deneyime sahip bir hukuk firmas\u0131d\u0131r. B\u00fcromuz, medya i\u015fletmecileri, inceleme sitesi i\u015fletmecileri, reklam ajanslar\u0131, D2C ve kozmetik \u00fcreticileri, klinikler, ASP i\u015fletmecileri gibi firmalara makale ve LP&#8217;nin hukuki kontrol\u00fc, y\u00f6nerge olu\u015fturma ve \u00f6rnekleme kontrol\u00fc gibi hizmetler sunmaktad\u0131r. Ayr\u0131nt\u0131lar a\u015fa\u011f\u0131daki makalede belirtilmi\u015ftir.<\/p>\n\n\n\n<p>Monolith Hukuk B\u00fcrosu&#8217;nun hizmet verdi\u011fi alanlar: <a href=\"https:\/\/monolith.law\/operationofmedia\" target=\"_blank\" rel=\"noreferrer noopener\">Makale ve LP&#8217;nin Japon \u0130la\u00e7 Kanunu vb. Kontrol\u00fc[ja]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>G\u00fcnl\u00fck ya\u015famda eksik kalan besinleri tamamlamak i\u00e7in takviye kullanmay\u0131 tercih eden bir\u00e7ok ki\u015fi bulunmaktad\u0131r. Takviyeler, eczanelerde ve benzeri yerlerde bulunabildi\u011fi gibi, teleshop programlar\u0131 ve d [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":64752,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[30,24],"acf":[],"_links":{"self":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61084"}],"collection":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/comments?post=61084"}],"version-history":[{"count":3,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61084\/revisions"}],"predecessor-version":[{"id":64753,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61084\/revisions\/64753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media\/64752"}],"wp:attachment":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media?parent=61084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/categories?post=61084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/tags?post=61084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}